Sfoglia per Autore
Proteasome inhibitors: Bortezomib in multiple myeloma
2008 Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G.; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M.
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients
2009 I. Iacobucci; M. Messina; N. Iraci; A. Lonetti; S. Chiaretti; A. Ferrari; C. Papayannidis; F Messa; A. Vitale; F. Paoloni; D. Cilloni; C T. Storlazzi; E. Ottaviani; S. Paolini; S. Durante; S. Soverini; R. Guarini; M. Vignetti; F. Pane; G. Saglio; R. Foà; M. Muschen; H. Pfifer; O. Ottmann; G. Perini; M. Baccarani; G Martinelli
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME
2009 I. Iacobucci; C.T. Storlazzi; A. Lonetti; A. Ferrari; E. Ottaviani; S. Chiaretti; M. Messina; D. Cilloni; C. Baldazzi; C. Papayannidis; F. Messa; A. Astolfi; S. Durante; A. Vitale; F. Arruga; F. Pane; P.P. Piccaluga; S. Colarossi; S. Soverini; M. Vignetti; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation
2009 Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.; Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M.
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients.
2009 Ilaria Iacobucci, Monica Messina, Nunzio Iraci, Annalisa Lonetti, Sabina Chiaretti, Anna Ferrari, Cristina Papayannidis, Francesca Messa, Antonella Vitale, Francesca Paoloni, Daniela Cilloni, Clelia Tiziana Storlazzi, Emanuela Ottaviani, Stefania Paolini, Sandra Durante, Simona Soverini, Rita Guarini, Marco Vignetti, Fabrizio Pane, Giuseppe Saglio, Robin Foà, Markus Muschen, Heike Pfifer, Oliver Ottmann, Giovanni Perini, Michele Baccarani, Giovanni Martinelli
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS
2010 Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M.
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)
2011 Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumma, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients.
2011 Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobucci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
2011 Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli
HIF 1 Alpha: A Suitable Target for Multiple Myeloma
2011 PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53
2011 TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNETTI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells
2011 A. Porro; N. Iraci; S. Soverini; D. Diolaiti; S. Gherardi; C. Terragna; S. Durante; E. Valli; T. Kalebic; R. Bernardoni; C. Perrod; M. Haber; M.D. Norris; M. Baccarani; G. Martinelli; G. Perini
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS
2012 V Guadagnuolo; C Papayannidis; I Iacobucci; S Durante; C Terragna; E Ottaviani; F Cattina; M Abbenante; S Soverini; L Toni; W Levin; R Courtney; C Baldazzi; A Curti; M Baccarani; C Jamieson; J Cortes; V Oehler; K McLachlan; T Van Arsdale; G Martinelli
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold
2012 Viviana Salvatore; Isabella Orienti; Stefano Focaroli; Sandra Durante; Monica Mattioli Belmonte; Mirella Falconi
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold
2012 Viviana Salvatore; Isabella Orienti; Stefano Focaroli; Sandra Durante; Monica Mattioli Belmonte and Mirella Falconi
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients
2012 Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307
2012 G Rosti; G Gugliotta; M Breccia; F Castagnetti; L Levato; A Capucci; M Tiribelli; A Zaccaria; M Bocchia; A Cuneo; F Stagno; G Specchia; M Musso; B Martino; M Cedrone; T Intermesoli; F Palandri; S Soverini; C Baldazzi; S Durante; N Testoni; G Alimena; F Pane; G Saglio; G Martinelli; M Baccarani
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study
2012 F Castagnetti; G Rosti; M Breccia; F Stagno; A Gozzini; G Specchia; A Capucci; B Martino; G Rege Cambrin; L Luciano; E Abruzzese; M Bocchia; F Cavazzini; M Tiribelli; I Pierri; G Gugliotta; F Palandri; S Durante; S Soverini; N Testoni; F Pane; G Saglio; G Alimena; G Martinelli; M Baccarani
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients
2012 Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cattina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G.
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.
2012 Iacobucci I.; Iraci N.; Messina M.; Lonetti A.; Chiaretti S.; Valli E.; Ferrari A.; Papayannidis C.; Paoloni F.; Vitale A.; Storlazzi C.T.; Ottaviani E.; Guadagnuolo V.; Durante S.; Vignetti M.; Soverini S.; Pane F.; Foà R.; Baccarani M.; Müschen M.; Perini G.; Martinelli G.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Proteasome inhibitors: Bortezomib in multiple myeloma | Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G....; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients | I. Iacobucci; M. Messina; N. Iraci; A. Lonetti; S. Chiaretti; A. Ferrari; C. Papayannidis; F Mess...a; A. Vitale; F. Paoloni; D. Cilloni; C T. Storlazzi; E. Ottaviani; S. Paolini; S. Durante; S. Soverini; R. Guarini; M. Vignetti; F. Pane; G. Saglio; R. Foà; M. Muschen; H. Pfifer; O. Ottmann; G. Perini; M. Baccarani; G Martinelli | 2009-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME | I. Iacobucci; C.T. Storlazzi; A. Lonetti; A. Ferrari; E. Ottaviani; S. Chiaretti; M. Messina; D. ...Cilloni; C. Baldazzi; C. Papayannidis; F. Messa; A. Astolfi; S. Durante; A. Vitale; F. Arruga; F. Pane; P.P. Piccaluga; S. Colarossi; S. Soverini; M. Vignetti; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation | Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.;... Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M. | 2009-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. | Ilaria Iacobucci, Monica Messina, Nunzio Iraci, Annalisa Lonetti, Sabina Chiaretti, Anna Ferrari,... Cristina Papayannidis, Francesca Messa, Antonella Vitale, Francesca Paoloni, Daniela Cilloni, Clelia Tiziana Storlazzi, Emanuela Ottaviani, Stefania Paolini, Sandra Durante, Simona Soverini, Rita Guarini, Marco Vignetti, Fabrizio Pane, Giuseppe Saglio, Robin Foà, Markus Muschen, Heike Pfifer, Oliver Ottmann, Giovanni Perini, Michele Baccarani, Giovanni Martinelli | 2009-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS | Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A....; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M. | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM) | Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumm...a, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients. | Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobuc...ci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients | Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, ...Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
HIF 1 Alpha: A Suitable Target for Multiple Myeloma | PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI ...P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 | TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNET...TI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells | A. Porro; N. Iraci; S. Soverini; D. Diolaiti; S. Gherardi; C. Terragna; S. Durante; E. Valli; T. ...Kalebic; R. Bernardoni; C. Perrod; M. Haber; M.D. Norris; M. Baccarani; G. Martinelli; G. Perini | 2011-01-01 | MOLECULAR CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS | V Guadagnuolo; C Papayannidis; I Iacobucci; S Durante; C Terragna; E Ottaviani; F Cattina; M Abbe...nante; S Soverini; L Toni; W Levin; R Courtney; C Baldazzi; A Curti; M Baccarani; C Jamieson; J Cortes; V Oehler; K McLachlan; T Van Arsdale; G Martinelli | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold | Viviana Salvatore; Isabella Orienti; Stefano Focaroli; Sandra Durante; Monica Mattioli Belmonte; ...Mirella Falconi | 2012-01-01 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | - | 4.02 Riassunto (Abstract) | - |
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold |
Viviana Salvatore; Isabella Orienti; Stefano Focaroli; Sandra Durante; Monica Mattioli Belmonte a...nd Mirella Falconi |
2012-01-01 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | - | 1.06 Abstract in rivista | - |
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients | Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; ...Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307 | G Rosti; G Gugliotta; M Breccia; F Castagnetti; L Levato; A Capucci; M Tiribelli; A Zaccaria; M B...occhia; A Cuneo; F Stagno; G Specchia; M Musso; B Martino; M Cedrone; T Intermesoli; F Palandri; S Soverini; C Baldazzi; S Durante; N Testoni; G Alimena; F Pane; G Saglio; G Martinelli; M Baccarani | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study | F Castagnetti; G Rosti; M Breccia; F Stagno; A Gozzini; G Specchia; A Capucci; B Martino; G Rege ...Cambrin; L Luciano; E Abruzzese; M Bocchia; F Cavazzini; M Tiribelli; I Pierri; G Gugliotta; F Palandri; S Durante; S Soverini; N Testoni; F Pane; G Saglio; G Alimena; G Martinelli; M Baccarani | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients | Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cat...tina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G. | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. | Iacobucci I.; Iraci N.; Messina M.; Lonetti A.; Chiaretti S.; Valli E.; Ferrari A.; Papayannidis ...C.; Paoloni F.; Vitale A.; Storlazzi C.T.; Ottaviani E.; Guadagnuolo V.; Durante S.; Vignetti M.; Soverini S.; Pane F.; Foà R.; Baccarani M.; Müschen M.; Perini G.; Martinelli G. | 2012-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | journal.pone.0040934.PDF |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile